Abstract
There are over 100 trillion microflorae in the human gut which engage in multiple interactions with human health during the whole life span. They influence human physiology, nutrition, metabolism and immunity. There is a two-way connection between the gut and brain known as gut-brain axis through which it influences the physiological, behavioural and cognitive functions of brain. This research focuses on the gut-brain axis, a bidirectional communication pathway between the gut and the brain that impacts brain function through vagus nerve and HPA axis and the metabolites such as neurotransmitters and SCFAs. The disruption in composition and relative abundance of gut microbiota known as dysbiosis leads to pathogenesis of several neurological disorders such as Alzheimer’s disease, Parkinson’s disease and autism. The individuals with neurological disorders presented with altered composition of gut microbes and its metabolites which varies from the normal individuals. This altered behaviour of gut microbes can be influenced or changed by supplementing with a bioactive live microorganisms known as probiotics. This study explores the potential of manipulating gut microbiota through probiotics to improve neurological function and potentially treat these disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK (2019) Microbiome-microglia connections via the gut-brain axis. J Exp Med 216:41–59
Ait-Belgnaoui A, Durand H, Cartier C et al (2012) Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37:1885–1895
Alzheimer’s Association (2020) 2020 Alzheimer’s disease facts and figures. Alzheimers Dement 5:234–270
Anglin R, Surette M, Moayyedi P, Bercik P (2015) Lost in translation: the gut microbiota in psychiatric illness. Can J Psychiatry 60(10):460–463. https://doi.org/10.1177/070674371506001007
Baj A, Moro E (2019) Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci 20:1482. https://doi.org/10.3390/ijms20061482
Benton D, Williams C, Brown A (2007) Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 61:355–361
Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C (2012) γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113:411–417
Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM, Verdu EF (2011) The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 23(12):1132–1139. https://doi.org/10.1111/j.1365-2982.2011.01796.x
Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H (2017) Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A 114(40):10719–10724. https://doi.org/10.1073/pnas.1711233114
Bienenstock J, Forsythe P, Karimi K, Kunze W (2010) Neuroimmune aspects of food intake. Int Dairy J 20:253–258
Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:49. https://doi.org/10.3389/fnins.2018.00049
Borsom EM, Lee K, Cope EK (2020) Do the bugs in your gut eat your memories? Relationship between gut microbiota and Alzheimer’s disease. Brain Sci 10(10):814. https://doi.org/10.3390/brainsci10110814
Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, Korecka A, Bakocevic N, Ng LG, Kundu P, Gulyás B, Halldin C, Hultenby K, Nilsson H, Hebert H, Volpe BT, Diamond B, Pettersson S (2014) The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med 6:263ra158
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:16050–16055
Briguglio M, Dell’Osso B, Panzica G, Malgaroli A, Banfi G, Dina CZ, Galentino R, Porta M (2018) Dietary neurotransmitters: a narrative review on current knowledge. Nutrients 10:591
Bruce-Keller AJ, Salbaum JM, Berthoud HR (2018) Harnessing gut microbes for mental health: getting from here to there. Biol Psychiatry 83(3):214–223. https://doi.org/10.1016/j.biopsych.2017.08.014
Buckley MM, O’Mahony SM, O’Malley D (2014) Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 20:8846–8858
Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A (2011) Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 17(12):1519–1528. https://doi.org/10.3748/wjg.v17.i12.1519
Capuco A, Urits I, Hasoon J, Chun R, Gerald B, Wang JK, Kassem H, Ngo AL, Abd-Elsayed A, Simopoulos T, Kaye AD, Viswanath O (2020) Current perspectives on gut microbiome dysbiosis and depression. Adv Ther 37(4):1328–1346. https://doi.org/10.1007/s12325-020-01272-7
Cerrato V (2020) Cerebellar astrocytes: much more than passive bystanders in ataxia pathophysiology. J Clin Med 9:757
Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical Excellence (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245
Chen T, Noto D, Hoshino Y, Mizuno M, Miyake S (2019) Butyrate suppresses demyelination and enhances remyelination. J Neuroinflammation 16:165
Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18:666–673
Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK (2009) Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A 106:14728–14733
Cloez-Tayarani I, Changeux JP (2007) Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol 81:599–606. https://doi.org/10.1189/jlb.0906544
De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M (2015) Autism spectrum disorders and intestinal microbiota. Gut Microbes 6(3):207–213
DeCastro M, Nankova BB, Shah P, Patel P, Mally PV, Mishra R, La Gamma EF (2005) Short chain fatty acids regulate tyrosine hydroxylase gene expression through a cAMP-dependent signaling pathway. Brain Res Mol Brain Res 142:28–38. https://doi.org/10.1016/j.molbrainres.2005.09.002
Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Núñez G, Martens EC (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339–1353.e21. https://doi.org/10.1016/j.cell.2016.10.043
Diamant M, Blaak EE, de Vos WM (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12(4):272–281. https://doi.org/10.1111/j.1467-789X.2010.00797.x
D’Mello C, Ronaghan N, Zaheer R et al (2015) Probiotics improve inflammation-associated sickness behavior by altering communication between the peripheral immune system and the brain. J Neurosci 35:10821–10830
Domingues C, da Cruz E Silva OAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer’s disease neuropathological hallmarks. Curr Alzheimer Res 14(8):870–882
Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, Arastu-Kapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H et al (2019) Porphyromonas gingivalis in Alzheimer’s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5(1):eaau3333. https://doi.org/10.1126/sciadv.aau3333
Dumitrescu L, Marta D, Danau A, Lefter A, Tulba D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO (2021) Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson’s disease. Front Neurosci 15:689723
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638. https://doi.org/10.1126/science.1110591
Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ (2017) 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain. Front Aging Neurosci 9:195
Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermöhlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965–977. https://doi.org/10.1038/nn.4030
Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF (2015) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol 14(6):625–639
Feehily C, Karatzas KA (2013) Role of glutamate metabolism in bacterial responses towards acid and other stresses. J Appl Microbiol 114:11–24
Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice. J Neurosci 23:9418–9427
Filosa S, Di Meo F, Crispi S (2018) Polyphenols-gut microbiota interplay and brain neuromodulation. Neural Regen Res 13(12):2055–2059. https://doi.org/10.4103/1673-5374.241429
Filpa V, Moro E, Protasoni M, Crema F, Frigo G, Giaroni C (2016) Role of glutamatergic neurotransmission in the enteric nervous system and brain-gut axis in health and disease. Neuropharmacology 111:14–33
Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H et al (2002) Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35(Suppl 1):S6–S16. https://doi.org/10.1086/341914
Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305–312. https://doi.org/10.1016/j.tins.2013.01.005
Fujisaka S, Avila-Pacheco J, Soto M, Kostic A, Dreyfuss JM, Pan H, Ussar S, Altindis E, Li N, Bry L, Clish CB, Kahn CR (2018) Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites. Cell Rep 22(11):3072–3086. https://doi.org/10.1016/j.celrep.2018.02.060
Fung KY, Cosgrove L, Lockett T, Head R, Topping DL (2012) A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 108:820–831
Furness JB, Callaghan BP, Rivera LR, Cho HJ (2014) The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol 817:39–71. https://doi.org/10.1007/978-1-4939-0897-4_3
Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–450. https://doi.org/10.1038/nature12721
Garden GA (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40:240–251
Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP, Freeman TC, Summers KM, McColl BW (2016) Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci 19:504–516
Gareau MG, Sherman PM, Walker WA (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7(9):503–514. https://doi.org/10.1038/nrgastro.2010.117
Garland EF, Hartnell IJ, Boche D (2022) Microglia and astrocyte function and communication: what do we know in humans? Front Neurosci 16:824888
Geirnaert A, Steyaert A, Eeckhaut V, Debruyne B, Arends JB, Van Immerseel F, Boon N, Van de Wiele T (2014) Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30:70–74. https://doi.org/10.1016/j.anaerobe.2014.08.010
Giau V, Wu S, Jamerlan A, An S, Kim S, Hulme J (2018) Gut microbiota and their neuroinflammatory implications in Alzheimer’s disease. Nutrients 10(11):1765
Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y (2018) Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson’s disease. Parkinsonism Relat Disord 50:108–112
Gruol DL (2023) The neuroimmune system and the cerebellum. Cerebellum. https://doi.org/10.1007/s12311-023-01624-3
Guinane CM, Cotter PD (2013) Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Ther Adv Gastroenterol 6(4):295–308. https://doi.org/10.1177/1756283X13482996
Haba R, Shintani N, Onaka Y, Wang H, Takenaga R, Hayata A, Baba A, Hashimoto H (2012) Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: possible role of activation of the central amygdala. Behav Brain Res 228(2):423–431. https://doi.org/10.1016/j.bbr.2011.12.027
Hahnen E, Hauke J, Trankle C, Eyupoglu IY, Wirth B, Blumcke I (2008) Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 17:169–184
Hemmer B, Kerschensteiner M, Korn T (2015) Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol 14(4):406–419. https://doi.org/10.1016/S1474-4422(14)70305-9
Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21:1359–1369
Hippius H, Neundörfer G (2003) The discovery of Alzheimer’s disease. Dialogues Clin Neurosci 5(1):101–108
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science. 291:881–884
Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999) Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135(5):559–563
Janik R, Thomason LAM, Stanisz AM, Forsythe P, Bienenstock J, Stanisz GJ (2016) Magnetic resonance spectroscopy reveals oral lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. NeuroImage 125:988–995. https://doi.org/10.1016/j.neuroimage.2015.11.018
Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D (2015) Role of the normal gut microbiota. World J Gastroenterol 21(29):8787–8803. https://doi.org/10.3748/wjg.v21.i29.8787
Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP (2015) Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 9:392. https://doi.org/10.3389/fncel.2015.00392
Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM (2015) Colonic bacterial composition in Parkinson’s disease. Mov Disord 30(10):1351–1360. https://doi.org/10.1002/mds.26307
Kidd PM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 12:207–227
Kobayashi Y, Sugahara H, Shimada K, Mitsuyama E, Kuhara T, Yasuoka A, Kondo T, Abe K, Xiao JZ (2017) Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer’s disease. Sci Rep 7:13510
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH et al (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576–585. https://doi.org/10.1038/nm.3145
Laurent RS, O’Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease. Neuroscience 246:382–390
Lay C, Sutren M, Rochet V, Saunier K, Doré J, Rigottier-Gois L (2005) Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ Microbiol 7(7):933–946. https://doi.org/10.1111/j.1462-2920.2005.00763.x
Levinthal DJ, Rahman A, Nusrat S, O’Leary M, Heyman R, Bielefeldt K (2013) Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis. Mult Scler Int 2013:319201. https://doi.org/10.1155/2013/319201
Li Q, Han Y, Dy ABC, Hagerman RJ (2017) The gut microbiota and autism spectrum disorders. Front Cell Neurosci 11:120
Liang L, Zhou H, Zhang S, Yuan J, Wu H (2017) Effects of gut microbiota disturbance induced in early life on the expression of extrasynaptic GABA-A receptor α5 and δ subunits in the hippocampus of adult rats. Brain Res Bull 135:113–119. https://doi.org/10.1016/j.brainresbull.2017.09.014
Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, Wang S, Tsai YC (2016) Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice. Brain Res 1631:1–12. https://doi.org/10.1016/j.brainres.2015.11.018
Liu F, Li J, Wu F, Zheng H, Peng Q, Zhou H (2019) Altered composition and function of intestinal microbiota in autism spectrum disorders: a systematic review. Transl Psychiatry 9(1):43
Lombardi VC, De Meirleir KL (2018) Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease. J Nutr Biochem 61:1–16
Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1–8
Lucerne KE, Osman A, Meckel KR, Kiraly DD (2021) Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 192:108598. https://doi.org/10.1016/j.neuropharm.2021.108598
MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F, Taylor AR, Kavaliers M, Ossenkopp KP (2007) Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 176:149–169. https://doi.org/10.1016/j.bbr.2006.07.025
Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67–72
Maes M, Simeonova D, Stoyanov D, Leunis JC (2019) Upregulation of the nitrosylome in bipolar disorder type 1 (BP1) and major depression, but not BP2: increased IgM antibodies to nitrosylated conjugates are associated with indicants of leaky gut. Nitric Oxide 91:67–76. https://doi.org/10.1016/j.niox.2019.07.003
Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14(2):183–193. https://doi.org/10.1016/S1474-4422(14)70256-X
Marín L, Miguélez EM, Villar CJ, Lombó F (2015) Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Biomed Res Int 2015:905215
Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF (2013) Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 21(4):167–173. https://doi.org/10.1016/j.tim.2012.12.001
Matsumoto M, Ooga T, Kibe R, Aiba Y, Koga Y, Benno Y (2017) Colonic absorption of low-molecular-weight metabolites influenced by the intestinal microbiome: a pilot study. PLoS One 12(2):e0169207
Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5(2):101–104. https://doi.org/10.1177/135245859900500206
Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12(8):453–466. PMID: 21750565
Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, Morita H, Hattori M, Yamamura T (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One 10(9):e0137429. https://doi.org/10.1371/journal.pone.0137429
Miyake Y, Tanaka K, Okubo H, Sasaki S, Furukawa S, Arakawa M (2018) Soy isoflavone intake and prevalence of depressive symptoms during pregnancy in Japan: baseline data from the Kyushu Okinawa Maternal and Child Health Study. Eur J Nutr 57(2):441–450. https://doi.org/10.1007/s00394-016-1327-5
Mulak A, Bonaz B (2004) Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monitor 10(4):RA55–RA62
Navarro F, Liu Y, Rhoads JM (2016) Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 22(46):10093–10102
Padhi P, Worth C, Zenitsky G, Jin H, Sambamurti K, Anantharam V, Kanthasamy A, Kanthasamy AG (2022) Mechanistic insights into gut microbiome dysbiosis-mediated neuroimmune dysregulation and protein misfolding and clearance in the pathogenesis of chronic neurodegenerative disorders. Front Neurosci 16:836605. https://doi.org/10.3389/fnins.2022.836605
Pannasch U, Rouach N (2013) Emerging role for astroglial networks in information processing: from synapse to behavior. Trends Neurosci 36:405–417
Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54:987–991
Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC (2015) Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37(5):984–995. https://doi.org/10.1016/j.clinthera.2015.04.002
Petra N, Petra CG, Zhang Z, Constantinescu EM, Anitescu M (2016. Nov 4) A Bayesian approach for parameter estimation with uncertainty for dynamic power systems. IEEE Trans Power Syst 32(4):2735–2743
Pistollato F, Cano SS, Elio I, Vergara MM, Giampieri F, Battino M (2016) Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer’s disease. Nutr Rev 74(10):624–634. https://doi.org/10.1093/nutrit/nuw023
Powell N, Walker MM, Talley NJ (2017) The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol 14(3):143–159. https://doi.org/10.1038/nrgastro.2016.191
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, MetaHIT Consortium, Bork P, Ehrlich SD, Wang JA (2010) Human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65. https://doi.org/10.1038/nature08821
Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health: a review. Brain Behav Immun 66:9–17
Rios AC, Maurya PK, Pedrini M, Zeni-Graiff M, Asevedo E, Mansur RB, Wieck A, Grassi-Oliveira R, McIntyre RS, Hayashi MAF, Brietzke E (2017) Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. Rev Neurosci 28(7):739–749. https://doi.org/10.1515/revneuro-2017-0001
Rothhammer V, Mascanfroni ID, Bunse L, Takenaka MC, Kenison JE, Mayo L, Chao CC, Patel B, Yan R, Blain M, Alvarez JI, Kébir H, Anandasabapathy N, Izquierdo G, Jung S, Obholzer N, Pochet N, Clish CB, Prinz M, Prat A et al (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22(6):586–597. https://doi.org/10.1038/nm.4106
Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao CC, Ardura-Fabregat A, de Lima KA, Gutiérrez-Vázquez C, Hewson P, Staszewski O, Blain M, Healy L, Neziraj T, Borio M, Wheeler M, Dragin LL, Laplaud DA, Antel J, Alvarez JI, Prinz M et al (2018) Microglial control of astrocytes in response to microbial metabolites. Nature 557(7707):724–728. https://doi.org/10.1038/s41586-018-0119-x
Roversi K, Callai-Silva N, Roversi K, Griffith M, Boutopoulos C, Prediger RD, Talbot S (2021) Neuro-immunity and gut dysbiosis drive Parkinson’s disease-induced pain. Front Immunol 12:759679
Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17(5):565–576. https://doi.org/10.1016/j.chom.2015.04.011
Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM (2000) Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15(7):429–435. https://doi.org/10.1177/088307380001500701
Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P (2015) Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord 30(3):350–358. https://doi.org/10.1002/mds.26069
Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Sharma M, Shukla G (2016) Metabiotics: one step ahead of probiotics; an insight into mechanisms involved in anticancerous effect in colorectal cancer. Front Microbiol 7:1940. https://doi.org/10.3389/fmicb.2016.01940
Shyamaladevi N, Jayakumar AR, Sujatha R, Paul V, Subramanian EH (2002) Evidence that nitric oxide production increases γ-amino butyric acid permeability of blood-brain barrier. Brain Res Bull 57:231–236
Skonieczna-Zydecka K, Jakubczyk K, Maciejewska-Markiewicz D, Janda K, Kaźmierczak-Siedlecka K, Kaczmarczyk M, Łoniewski I, Marlicz W (2020) Gut biofactory—neurocompetent metabolites within the gastrointestinal tract. A scoping review. Nutrients 12:3369. https://doi.org/10.3390/nu12113369
Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI (2005) Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 307:1955–1959
Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y (2004) Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558(Pt 1):263–275. https://doi.org/10.1113/jphysiol.2004.063388
Sun X, Meng X, Zhang J, Li Y, Wang L, Qin X, Sui N, Zhang Y (2012) GABA attenuates amyloid toxicity by downregulating its endocytosis and improves cognitive impairment. J Alzheimers Dis 31:635–649
Takanaga H, Ohtsuki S, Hosoya K-I, Terasaki T (2001) GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 21:1232–1239
Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, Prasad PD, Ganapathy V (2009) GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69:2826–2832. https://doi.org/10.1158/0008-5472.CAN-08-4466
Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D (2015) Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138:179–187. https://doi.org/10.1016/j.physbeh.2014.10.033
Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489(7415):242–249. https://doi.org/10.1038/nature11552
Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M (2020) The controversial role of human gut Lachnospiraceae. Microorganisms 8(4):573. https://doi.org/10.3390/microorganisms8040573
Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4(4):623–632. https://doi.org/10.1038/s41564-018-0337-x
Valsecchi C, Carlotta Tagliacarne S, Castellazzi A (2016) Gut microbiota and obesity. J Clin Gastroenterol 50:S157–S158. https://doi.org/10.1097/MCG.0000000000000715
Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, Cohen J, Mannangatti P, Jessen T, Thompson BJ, Ye R, Kerr TM, Carneiro AM, Crawley JN, Sanders-Bush E, McMahon DG, Ramamoorthy S, Daws LC, Sutcliffe JS, Blakely RD (2012) Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 109(14):5469–5474. https://doi.org/10.1073/pnas.1112345109
Verma A, Shukla G (2014) Synbiotic (Lactobacillus rhamnosus+Lactobacillus acidophilus+inulin) attenuates oxidative stress and colonic damage in 1,2 dimethylhydrazine dihydrochloride-induced colon carcinogenesis in Sprague-Dawley rats: a long-term study. Eur J Cancer Prev 23(6):550–559. https://doi.org/10.1097/CEJ.0000000000000054
Verna EC, Lucak S (2010) Use of probiotics in gastrointestinal disorders: what to recommend? Ther Adv Gastroenterol 3(5):307–319. https://doi.org/10.1177/1756283X10373814
Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson’s disease. Nat Med 10(Suppl):S58–S62
Vitetta L, Bambling M, Alford H (2014) The gastrointestinal tract microbiome, probiotics, and mood. Inflammopharmacology 22:333–339. https://doi.org/10.1007/s10787-014-0216-x
Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE (2017) Gut microbiome alterations in Alzheimer’s disease. Sci Rep 7(1):13537. https://doi.org/10.1038/s41598-017-13601-y
Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27(4):427–448
Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H (2020) Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis 6:11. https://doi.org/10.1038/s41531-020-0112-6
Wang HX, Wang YP (2016) Gut microbiota-brain axis. Chin Med J 129(19):2373–2380. https://doi.org/10.4103/0366-6999.190667
Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, Xie Z, Chu X, Yang J, Wang H, Chang S, Gong Y, Ruan L, Zhang G, Yan S, Lian W, Du C, Yang D, Zhang Q, Lin F et al (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res 29(10):787–803. https://doi.org/10.1038/s41422-019-0216-x
Wekerle H (2017) Brain autoimmunity and intestinal microbiota: 100 trillion game changers. Trends Immunol 38(7):483–497. https://doi.org/10.1016/j.it.2017.03.008
Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264–276. https://doi.org/10.1016/j.cell.2015.02.047
Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, Xiang ZB, Xu RS (2022) Association between inflammatory bowel diseases and Parkinson’s disease: systematic review and meta-analysis. Neural Regen Res 17(2):344–353
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jayaraman, S., Paul, S. (2024). Gut Microbiota and Altered Behaviour: Target on Neuroimmune Interplays. In: Pathak, S., Banerjee, A. (eds) Gut Microbiome and Brain Ageing. Springer, Singapore. https://doi.org/10.1007/978-981-99-8803-7_9
Download citation
DOI: https://doi.org/10.1007/978-981-99-8803-7_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8802-0
Online ISBN: 978-981-99-8803-7
eBook Packages: MedicineMedicine (R0)